CEACAM5 and neoplasm: To more broadly characterize the molecular parameters associated with CEA-TCB treatment we performed bulk RNA sequencing of CEA-TCB-treated (seven consecutive treatments) and untreated tumors derived from MKN-45 tumor-bearing humanized mice (experiment from Figure 1; GEO accession number GSE155887).